Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT04262388. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03406247. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05183048. IPD Sharing: NO. Countries: 1. Publications: 0.
Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck
ClinicalTrials.gov study NCT00216138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multimodal Prediction of Response to Chemoradiotherapy for Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT07259915. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07219212. IPD Sharing: YES. Countries: 1. Publications: 0.
Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck
ClinicalTrials.gov study NCT01301248. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT05108090. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
ClinicalTrials.gov study NCT04868162. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck
ClinicalTrials.gov study NCT01275183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT05376553. IPD Sharing: YES. Countries: 1. Publications: 0.
A Biomarker-driven, Open Label, Single Arm, Multicentre Phase II Study of Abemaciclib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Who Failed to Platinum-based Therap
ClinicalTrials.gov study NCT03356587. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck
ClinicalTrials.gov study NCT01577173. IPD Sharing: Not stated. Countries: 11. Publications: 0.
An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.
ClinicalTrials.gov study NCT02145312. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
ClinicalTrials.gov study NCT06557889. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00934518. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT06744296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
ClinicalTrials.gov study NCT06162377. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04440917. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04146181. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.